# Baijin Life Science Holdings Limited (MNNGF)

> 医疗保健 · HK · 以 HKD 报告

Sponda 的基本面指标，已按通胀调整。

[HTML 版本](https://sponda.capital/zh/MNNGF/fundamentals)

## 年度数据

| 年份 | 营业收入 (M) | 净利润 (M) | FCF (M) | 债务 (M) | 股东权益 (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | HK$ 89.25M | HK$ -37.85M | HK$ -22.55M | HK$ 28.40M | HK$ 185.09M |
| 2025 | HK$ 135.56M | HK$ -316.0K | HK$ -32.97M | HK$ 99.93M | HK$ 139.28M |
| 2024 | HK$ 41.12M | HK$ -7.45M | HK$ -5.63M | HK$ 51.19M | HK$ 96.31M |
| 2023 | HK$ 86.88M | HK$ 8.68M | HK$ -22.84M | HK$ 2.76M | HK$ 78.34M |
| 2022 | HK$ 62.65M | HK$ -15.46M | HK$ -2.14M | HK$ 31.84M | HK$ 35.87M |
| 2021 | HK$ 43.32M | HK$ -51.79M | HK$ -20.39M | HK$ 31.56M | HK$ 45.95M |
| 2020 | HK$ 111.98M | HK$ -281.82M | HK$ -8.25M | HK$ 39.50M | HK$ 85.13M |
| 2019 | HK$ 171.27M | HK$ -42.82M | HK$ -24.04M | HK$ 52.50M | HK$ 197.98M |
| 2018 | HK$ 187.36M | HK$ -129.79M | HK$ 81.95M | HK$ 0 | HK$ 236.51M |
| 2017 | HK$ 212.23M | HK$ -23.89M | HK$ -89.70M | HK$ 0 | HK$ 290.09M |
| 2016 | HK$ 210.02M | HK$ -10.94M | HK$ -20.97M | HK$ 0 | HK$ 313.66M |
| 2015 | HK$ 270.71M | HK$ 10.06M | HK$ -17.48M | HK$ 45.20M | HK$ 267.60M |
| 2014 | HK$ 268.47M | HK$ 29.60M | HK$ 19.50M | HK$ 47.60M | HK$ 398.86M |

此视图中不可用的列：annualPriceMultiples, dividends。它们需要实时市场数据，仅在 HTML 页面上显示。

## 杠杆与流动性

| 指标 | 数值 |
| --- | --- |
| 总债务 / 股东权益 | 0.15 |
| 总负债 / 股东权益 | 0.39 |
| 流动比率 | 2.97 |

## 其他视图

- [指标](https://sponda.capital/zh/MNNGF.md)
- [图表](https://sponda.capital/zh/MNNGF/charts.md)
- [对比](https://sponda.capital/zh/MNNGF/compare.md)
- [指标定义](https://sponda.capital/zh/screener.md)

数据截至 2026-08-29。